Compare PFBC & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFBC | FLGT |
|---|---|---|
| Founded | 1991 | 2011 |
| Country | United States | United States |
| Employees | 324 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 867.4M |
| IPO Year | N/A | 2016 |
| Metric | PFBC | FLGT |
|---|---|---|
| Price | $88.60 | $15.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $102.67 | $28.33 |
| AVG Volume (30 Days) | 83.9K | ★ 728.2K |
| Earning Date | 04-24-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $18,730,000.00 |
| Revenue This Year | $2.94 | $10.66 |
| Revenue Next Year | $8.31 | $12.17 |
| P/E Ratio | $8.85 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $73.08 | $13.46 |
| 52 Week High | $103.05 | $31.04 |
| Indicator | PFBC | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 47.26 | 33.24 |
| Support Level | $88.78 | $13.46 |
| Resistance Level | $93.52 | $22.48 |
| Average True Range (ATR) | 2.40 | 0.69 |
| MACD | -0.01 | 0.30 |
| Stochastic Oscillator | 62.20 | 87.76 |
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking, which include Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.